Kymera Therapeutics, Inc. Ratios

Ratios Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
EBT Margin -1,440.05%-136.39%-138.27%-344.75%-210.87%-8,447.87%
EBIT Margin -1,438.48%-136.05%-138.03%-344.37%-210.62%-8,439.84%
EBITDA Margin -1,405.59%-134.36%-138.33%-339.76%-181.40%-7,251.32%
Operating Margin -1,438.48%-136.05%-138.03%-344.37%-210.62%-8,439.84%
Net Margin -1,405.79%-160.55%-138.27%-330.60%-186.99%-7,221.23%
FCF Margin 592.13%232.22%-179.24%-332.98%-174.71%-6,688.35%
Efficiency
Assets Average 301.94M546.54M604.52M589.45M776.90M
Equity Average 104.74M371.76M474.89M442.56M615.29M
Invested Capital -74.41M283.89M459.64M490.15M394.97M835.62M
Asset Utilization Ratio 0.110.130.080.130.00
Leverage & Solvency
Interest Coverage Ratio -917.50-402.64-574.46-916.23-844.54-0.00M
Equity Ratio -0.640.580.760.810.690.85
Times Interest Earned -917.50-402.64-574.46-916.23-844.54-0.00M
Valuation
Enterprise Value -91.96M2,460.25M2,820.15M1,422.72M2,099.53M1,475.82M
Market Capitalization 2,756.45M3,262.57M1,829.89M2,474.41M1,964.56M
Return Ratios
Return on Sales -14.40%-1.36%-1.38%-3.45%-2.11%-84.48%
Return on Capital Employed -0.24%-0.22%-0.30%-0.33%-0.37%
Return on Assets -0.15%-0.18%-0.27%-0.28%-0.34%
Return on Equity -0.44%-0.27%-0.34%-0.37%-0.43%